Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : P-Borono-L-Phenylalanine
Therapeutic Area : Oncology
Study Phase : Approved
Sponsor : TAE Life Sciences
Deal Size : Undisclosed
Deal Type : Collaboration
TAE and Stella Collaborate On BPA for BNCT Cancer Therapy Development
Details : The collaboration aims to focus on the development, commercialization and expansion of boron neutron capture therapy using Steboronine (boronophenylalanine) in the United States and European markets.
Brand Name : Steboronine
Molecule Type : Small molecule
Upfront Cash : Undisclosed
November 13, 2024
Lead Product(s) : P-Borono-L-Phenylalanine
Therapeutic Area : Oncology
Highest Development Status : Approved
Sponsor : TAE Life Sciences
Deal Size : Undisclosed
Deal Type : Collaboration
LOOKING FOR A SUPPLIER?